$DVA

DaVita Inc

  • NEW YORK STOCK EXCHANGE INC.
  • Health Services
  • Medical/Nursing Services
  • Health Care and Social Assistance
  • Kidney Dialysis Centers

PRICE

$97.78 -

Extented Hours

VOLUME

465,976

DAY RANGE

95.48 - 98.14

52 WEEK

91.73 - 136.48

Join Discuss about DVA with like-minded investors

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Friday, October 29, 2021 Futures Up/Down % Last Dow -45.00 0.13% 35,568 S&P 500 -22.25 0.49% 4,565 Nasdaq -139.50 0.88% 15,625 After trading to all-time highs Thursday for the S&P 500, Dow Jones, and Nasdaq Composite (and a 2% gain for the Russell 2000 as well) on strong earnings as well as positive developments on the spending bill in Washington, futures are pulling back. Shares of tech and retail giants Apple (AAPL) and Amazon (AMZN) are lower by 3% and 4% respectively after AAPL’s iPhone and overall revs miss for the quarter and AMZN drops on a Q3 revs miss, lower op income and lower guidance, sending Nasdaq Futures lower by about 1%. Investor sentiment is also starting to turn cautious amid the steady stream of corporate warnings on inflationary pressures and supply chain woes. Big day of inflation data with the personal spending and income for Sept and PCE inflation data expected at 8:30 AM. The 10-year Treasury yield is up around 1.61%, recovering off mid-week lows around the mid 1.5% level. Bitcoin prices are lower holding around the $60K level while oil futures are on track to snap their 8-week winning streak. In Asian markets, The Nikkei Index rises 0.25% to 28,890, the Shanghai Index gains 0.8% to 3,547, and the Hang Seng Index falls =0.7% to 25,377. In Europe, the German DAX is lower -1.2% to 15,500, while the FTSE 100 down -0.5% at 7,210. Market Closing Prices Yesterday The S&P 500 Index gained 44.74 points, or 0.98%, to 4,596.42 The Dow Jones Industrial Average rose 239.79 points, or 0.68%, to 35,730.48 The Nasdaq Composite surged 212.28 points, or 1.39%, to 15,448.12 The Russell 2000 Index advanced 45.49 points, or 2.02% to 2,297.98 Events Calendar for Today 8:30 AM ET Personal Income for September…est. (-0.2%) 8:30 AM ET Personal Spending for September…prior +0.4% 8:30 AM ET PCE Price Index MoM for September 8:30 AM ET PCE Price Index YoY for September 8:30 AM ET Core PCE Price Index MoM for September…est. +0.2% 8:30 AM ET Core PCE Price Index YoY for September…est. +3.7% 9:45 AM ET Chicago PMI for October…est. 63.5 (prior 64.7) 10:00 AM ET University of Michigan Confidence, Oct-F…est. 71.4 1:00 PM EST Baker Hughes Weekly rig count data Earnings Calendar: Earnings Before the Open: ABBV, AON, B, BAH, CERN, CHD, CHTR, CL, COWN, CVX, DCOM, HUN, IRMD, LHX, PIPR, POR, PSX, PSXP, RUTH, WY, XOM Macro Up/Down Last Nymex 0.34 83.15 Brent 0.37 84.69 Gold -2.95 1,795.95 EUR/USD -0.0029 1.1652 JPY/USD 0.19 113.76 10-Year Note +0.041 1.61% Sector News Breakdown Consumer com (AMZN) shares fall -3%; 3Q EPS $6.12 vs est. $8.92 on sales $110.8B vs est. $111.6B, AWS net sales $16.11B; guides 4Q sales $130-140B vs est. $142B; sees q4 operating income is expected to be between $0 and $3.0 bln, compared with $6.9 bln in q4 2020; in q4, expect to incur several bln dollars of additional costs in consumer business as we manage through labor supply shortages Starbucks (SBUX) Q4 EPS $1.00 vs. est. $0.99; Q4 revs rose 31% to $8.1B vs. est. $8.21B; commits to $20 bln of share repurchases and dividends over next three years; qtrly active Starbucks rewards membership in U.S. approaches 25 mln, up 28% YoY; qtrly comp store sales of 17% globally; qtrly international comp store sales grew 3%; qtrly comp store sales of 22% in U.S.; comp store sales decreased 7% in China Columbia Sportswear (COLM) 3Q EPS $1.52 vs est. $1.33 on revs $804.7Mm vs est. $862Mm; qtrly inventory -7%; guides FY net sales +21.5-23% vs prior +25-26.5% and est. +26.5%, sees FY EPS $4.55-4.80 vs est. $4.65; says believe can achieve mid-teens or better net sales growth in 2022 vs est. +10% Decker’s Outdoors (DECK) 2Q EPS $3.66 vs est. $4.00 on sales $721.9Mm vs est. $765.9Mm, comps +1%; sees FY EPS $14.15-15.15 vs est. $15.15; Gross margin was 50.9% compared to 51.2% for the same period last year; Decker’s also said: UGG(R) brand net sales for the second quarter increased 8.0% to $448.4 million compared to $415.1 million for the same period last year. HOKA(R) brand net sales for the second quarter increased 47.0% to $210.4 million compared to $143.1 million for the same period last year. Teva(R) brand net sales for the second quarter increased 4.0% to $28.8 million compared to $27.7 million for the same period last year. Frontdoor (FTDR) 3Q EPS $0.89 vs est. $0.68 on revs $471Mm vs est. $476.5Mm; guides 4Q revs $330-340Mm vs est. $347.7Mm, sees FY revs $1.59-1.6B vs est. $1.62B Mohawk Industries (MHK) Q3 adj EPS $3.95 vs. est. $3.81; Q3 revs $2.817B vs. est. $2.9B; guides Q4 EPS $2.80-$2.90 vs. est. $3.23 Skecher’s (SKX) Q3 EPS $0.66 vs. est. $0.73; Q3 sales rose 19.2% to $1.55B vs. est. $1.63B; guides Q4 EPS $0.28-$0.33 vs. est. $0.34 and year EPS view cut to $2.45-$2.50 from $2.55-$2.65; cuts FY21 revenue view to $6.15B-$6.2B from $6.15B-$6.25B; Direct-to-Consumer sales grew 44.1% and wholesale sales grew 10.5% SkyWest (SKYW) 3Q adj EPS $1.45 vs est. $0.70 on revs $745Mm vs est. $687.7Mm; says experienced a severe outage in October resulting in about 1,700 flight cancelations and expect may impact 4Q results from $15-20Mm pre-tax; Texas Roadhouse (TXRH) Q3 EPS $0.75 vs est. $0.81 on revenue $869.9M vs est. $869.4M; comp sales +30.2% vs 3Q20, +22.3% vs 2019, partially offset by higher food/beverage costs with commodity inflation 13.9% driven by higher beef prices; sees positive comp sales in FY22, commodity cost inflation in high-teens in 1H22 Energy Chevron (CVX) Q3 adj EPS $2.96 vs. est. $2.21; Q3 revs $43B vs. est. $40.52B; posted net income of $6.11B vs. a loss of $207M a year ago; said Q3 average sales price per barrel of crude oil and natural gas liquids was $58, vs $31 a year earlier Dril-Quip (DRQ) 3Q EPS ($0.31) vs est. ($0.14) on revs $83Mm vs est. $85.6Mm, sees 4Q bookings at high end of $40-60Mm range (unchanged from prior view) First Energy (FE) Q3 adj EPS $0.82 vs. est. $0.79; Q3 revs $3.1B in-line with ests; raises FY21 adj EPS view to $2.55-$2.65 from $2.40-$2.60 (est. $2.54) SM Energy (SM) Q3 EPS $0.69 vs. est. $0.13; Q3 revs $760.24M vs. est. $510.61M; Q3 Production was 14.3 MMBoe (155.8 MBoe/d) and was 56% oil; the Company is increasing guidance for 2021 production volumes to 49.5-50.0 MMBoe (135.6-137.0 MBoe/d) Financials Hartford Financial (HIG) Q3 core EPS $1.26 vs. est. $0.86; Net income ROE for the trailing 12-month period ended Sept. 30, 2021 was 12.3% and core earnings ROE* for the same period was 12.5%; the Commercial Lines combined ratio was 101.2 in third quarter 2021 with an underlying combined ratio* of 87.2, a 6.5-point improvement YoY LPL Financial (LPLA) Q3 EPS $1.77 vs est. $1.75 on revenue $2.02B vs est. $2.05B; total advisory and brokerage assets $1.13 trillion (+40% YoY), organic net new assets $27B (+10% annualized) in the qtr, $110B over past 12-months (+14% annualized) Riley Financial (RILY) announced a $4 dividend, composed of a $3 special one-time payout and a doubling of its regular quarterly dividend to $1 Healthcare 4D Molecular (FDMT)75M share Secondary priced at $25.00 AirSculpt Technologies (AIRS) 7M share IPO priced at $11.00 Aura Biosciences (AURA) 5M share IPO priced at $14.00 Entrada Therapeutics (TRDA)075M share IPO priced at $20.00 Sonendo (SONX)8M share IPO priced at $12.00 Valneva (VALN)5M share Secondary priced at $39.42 Acadia Healthcare (ACHC) Q3 adj EPS in-line at $0.72; Q3 revs $587.6M vs. est. $590.9M; Q3 same facility revenue increased 7.9% YoY, including an increase in revenue per patient day of 5.6% and an increase in patient days of 2.2%; same facility adjusted EBITDA margin was 29.0%; narrowed 2021 revenue to $2.295B-$2.315B vs. est. $2.31B CareDX (CDNA) Q3 adj EPS 7c vs est. 1c on revenue $75.6M vs est. $74M; raised FY21 revenue forecast to $290M-$293M from $280M-$290M DaVita Inc. (DVA) 3Q EPS $2.36 vs est. $2.25 on revs $2.94B, says US dialysis treatments averaged 94,509/day; guides FY adj EPS $8.80-9.15 vs est. $9.19 Dexcom (DXCM) Q3 EPS $0.71 vs. est. $0.63; Q3 revs $650.2M vs. est. $617.82; Based on the strong third quarter results, Dexcom is increasing its guidance for fiscal year 2021 revenue, Non-GAAP gross profit margin, Non-GAAP operating margin, and Adjusted EBITDA margin Gilead Sciences (GILD) 3Q adj EPS $2.65 vs est. $1.75 on revs $7.4B vs est. $6.3B; guides FY total product sales $26-26.3B vs est. $25.14B (sees $21.5B ex Veklury); guides FY adj EPS $7.90-8.10 vs est. $7.19 Nextgen health (NXGN) 2Q adj EPS $0.29 vs est. $0.23 on revs $149.3Mm vs est. $143.4Mm; guides FY revs $584-590Mm vs est. $582.4Mm, sees FY adj EPS $0.90-0.96 vs est. $0.93; says may repurchase up to $60Mm of its outstanding shares through March 2023 PTC Therapeutics (PTCT) Q3 EPS loss ($1.89) vs. est. loss ($1.40); Q3 revs $139M vs. est. $126.44M; raises FY21 rev view for DMD franchise to $400M-$420M from $370M-$390M and narrows R&D and SG&A expenses to $815M-$835M from $825M-$855M. ResMed (RMD) 1Q EPS $1.39 vs est. $1.36 on revs $904Mm vs est. $860.9Mm Seagen (SGEN) Q3 EPS ($1.61) vs est. $(0.58) on revenue $424.1M vs est. $383.1M, total net product sales $366.5M (+37% YoY) Stryker (SYK) Q3 adj EPS $2.20 vs. est. $2.28; Q3 revs $4.16B vs. est. $4.23B; Q3 organic net sales increased 4.5%; raises FY21 adjusted EPS view to $9.08-$9.15 from $8.80-$9.20 (est. $9.30); said now expect 2021 organic net sales growth to be in the range of 7% to 8% from 2019 Industrials & Materials Eastman Chemical (EMN) 3Q adj EPS $2.46 vs est. $2.46 on revs $2.72B vs est. $2.6B; guides FY EPS $8.80-9.00 vs est. $9.09, sees FY FCF about $1.1B; says implementing price increases across specialty product lines to offset higher costs, expect to be caught up in early 2022 Ecolab (ECL) to acquire Purolite, a leading global provider of fast-growing, high value separation and purification solutions to life sciences and critical industrial markets; Ecolab to pay approximately $3.7 billion in cash Fortive (FTV) Q3 adj EPS $0.66 vs. est. $0.65; Q3 revs $1.3B vs. est. $1.32B; raises FY21 adj EPS view to $2.70-$2.75 from $2.65-$2.75 (est. $2.72); said Delivered significant margin improvement, strong adjusted operating margin expansion and robust cash flow growth Hub Group (HUBG) Q3 EPS $1.28 vs est. $1.10 on in-line revs $1.08B; raises FY21 EPS $3.90-$4 from $3.50-$3.70 vs est. $3.66, still sees rev growth in the high-teens Huntington Ingalls (HII) 2Q adj EPS $1.71 vs est. $1.17 on revs $537Mm vs est. $375.6Mm L3Harris Technologies (LHX) raises FY21 adjusted EPS view to $12.85-$13.00 from $12.80-$13.00 and lowers FY21 revenue view to approximately $17.9B from $18.1B-$18.5B Mercer Int’l (MERC) 3Q EPS $1.04 vs est. $0.83 on revs $469.7Mm vs est. $452.9Mm Polymetal International PLC (POLY) 2Q adj EPS $0.77 vs est. $0.56 on revs $419Mm vs est. $428.4Mm; guides FY adj EPS $2.30-2.70 vs est. $3.10, sees FY revs $1.675-1.725B vs est. $1.8B Republic Service (RSG) 3Q adj EPS $1.11 vs est. $1.05 on revs $2.93B vs est. $2.84B; guides FY adj EPS $4.10-4.13 from prior $4.00-$4.05 and vs est. $4.05 Terex Corp. (TEX) 3Q EPS $0.67 vs est. $0.72 on sales $993.8Mm vs est. $1.0B; guides FY sales $3.85B vs est. $3.86B, sees FY EPS $2.75-2.85 vs est. $2.82 Werner Enterprise (WERN) Q3 EPS $0.94 vs. est. $0.95; Q3 revs $702.9M vs. est. $700.8M S. Steel (X) announces a $300 million stock repurchase program and increases its quarterly dividend to $0.05 per share; Q3 adjusted EPS $5.36 tops consensus $4.85; Q3 revs $5.96B vs. est. $5.79B

120 Replies 14 👍 9 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Thursday, October 28, 2021 Futures Up/Down % Last Dow 54.00 0.15% 35,443 S&P 500 11.25 0.26% 4,556 Nasdaq 74.50 0.47% 15.662 U.S. futures are looking at a rebound after a late day swoon erased record gains for stocks, as markets again await another earnings barrage, with yesterday and today the two busiest days of the quarter. Drama out of Washington D.C. also adding to the volatility as investors remain hopeful on a spending bill. As for Wednesday, a midday all-time high for the Nasdaq 100 was marred by a late day sell-off in U.S. stocks, as the S&P 500 and Dow each retreated from records set just the previous day, led by weakness in energy stocks as oil prices tumbled from 7-year highs and long-dated Treasury yields also slumped, with the 30-year falling as much as 10bps below 2%. Corporate earnings have generally been better-than-expected, but constant reminders about rising costs, supply-chain issues, and labor shortages on conference calls brings into question the strength of markets going forward. Couple that with expectations for the Fed to begin its asset tapering plans in November and chances of interest rate hikes in mid-2022 to help prevent inflation getting further out of hand remains a market concern. Shares of Dow components McDonald’s, Coca-Cola and Microsoft rallied behind strong earnings. In fact, the Nasdaq outperformed behind large cap winners (TSLA, GOOGL MSFT, AMZN), though breadth was decisively negative and SmallCaps plunged with the Russell 200 falling nearly 2%. President Biden’s infrastructure and social-spending plans still remain “up-in-the-air” which also adds uncertainty. In Asian markets, The Nikkei Index fell about 1% to 28,820, the Shanghai Index slipped -1.23% to 3.518 and the Hang Seng Index dipped about -0.25% to 25,555. In Europe, the German DAX is down -0.15% at 15,680, while the FTSE 100 is also down roughly -0.2% at 7,240. Market Closing Prices Yesterday The S&P 500 Index dropped -23.11 points, or 0.51%, to 4,551.68 The Dow Jones Industrial Average fell -266.19 points, or 0.74%, to 35,490.69 The Nasdaq Composite little changed, or 0.00%, to 15,235.84 The Russell 2000 Index declined -43.58 points, or 1.90% to 2,252.49 Events Calendar for Today 8:30 AM ET Weekly Jobless Claims…est. 290K 8:30 AM EST Continuing Claims…est. 2.415M 8:30 AM ET Gross Domestic Product (GDP) for Q3-A…est. 2.7% (down from prior) 8:30 AM ET GDP Consumer Spending for Q3-A…prior month 12.0% 8:30 AM ET GDP Price Deflator for Q3…est. 5.5% 8:30 AM ET Core-PCE Prices Advance for Q3…est. 4.5% 10:00 AM ET Pending Home Sales MoM for September…est. 0% 10:30 AM ET Weekly EIA Natural Gas Inventory Data 11:00 AM ET Kansas City Fed Manufacturing for October 1:00 PM ET U.S. to sell $62 bln 7-year notes Earnings Calendar: Earnings Before the Open: AB, ABMD, ADS, AEP, AGCO, ALNY, AMT, AOS, ATI, BAX, BC, BSIG, BTU, CARR, CAR, CBRE, CBZ, CFR, CG, CMCO, CMCSA, CMS, CNX, COLB, CONE, COOP, COR, CWT, DBD, EME, EXP, FCN, GPI, GVA, HBAN, HSY, IBP, ICE, ITW, KBR, KDP, KEX, LECO, LH, LKQ, MA, MCO, MDD, MO, MRK, NEM, NLSN, NOC, OSK, OSIS, OSTK, PBF, RGEN, RLGY, RS, SAH, SAIA, SNDR, SWI, SWK, TAP, TFX, TPX, TREE, TW, TXT, VC, VLY, WEX, WST, XEL, YUM Earnings After the Close: AAPL, ABCB, ACHC, AGL, AMZN, ASPN, ATEN, ATR, AVT, AX, BIO, BY, CDNA, CHE, COHU, COLM, CPT, CUZ, CWST, DECK, DVA, DXCM, EB, EMN, FISI, FTDR, FTV, GILD, HIG, HUBG, LOPE, LPLA, LTC, NGRC, MHK, MMSI, MPWR, MSTR, NATI, NXGN, PEB, POWI, PSB, PTCT, QUMU, RMD, RSG, SBCF, SBUX, SGEN, SKX, SKYW, SM, SPNE, SSNC, SYK, TEX, TXRH, VCRA, VRSN, WDC, WRAP, WRE, X, ZEN Macro Up/Down Last Nymex -1.61 81.05 Brent -1.37 83.21 Gold -2.10 1,801.20 EUR/USD -0.0006 1.1598 JPY/USD -0.23 113.57 10-Year Note +0.012 1.541% Sector News Breakdown Consumer eBay Inc. (EBAY) 3Q adj EPS $0.90 vs est. $0.89 on revs $2.5B vs est. $2.46B; guides 4Q adj EPS $0.72-0.76 vs est. $1.00, sees 4Q revs $2.57-2.62B vs est. $2.65B; raising estimated FY share buyback from $5.0B to $7.0B Ford Motor (F) announces resumption of stock dividend in 4q; 3Q adj EPS $0.51 vs est. $0.27 on revs $35.7B vs est. $32.5B; expects cash flow over current planning period to be more than sufficient to fund growth, announces resumption of regular stock dividend in 4Q; no changes to FY adj FCF guide of $4.0-5.0B Boot Barn (BOOT) Q2 EPS $1.25 vs est. $0.93 on revenue $312.7M (+67.1% vs 2Q19) vs est. $291M, same-store sales +61.7% YoY, +53.6% vs 2019; sees new unit growth 10% in FY22; named Jim Watkins as CFO with current CFO Greg Hackman continuing as VP and COO Churchill Downs (CHDN) 3Q EPS $1.57 vs est. $1.47 on revs $393Mm vs est. $406.8Mm Fresh Del Monte Produce Inc. (FDP) said it is raising prices on bananas, pineapples and fresh-cut fruit in response to unprecedented market conditions and inflationary pressures being felt across all industries iRobot (IRBT) Q3 EPS $1.67 vs. est. $0.70; Q3 revs $440.7M vs. est. $417.04M; cuts FY21 non-GAAP EPS view to $1.15-$1.74 from $2.25-$3.15 (est. $2.70) and lowers FY21 revenue view to $1.56B-$1.59B from $1.55B-$1.62B (est. $1.58B) Noodles (NDLS) Q3 adj EPS 12c vs est. 9c on in-line revenue $125.1M with digital sales 52% of total revs; system-wide comp sales +16.3% vs est. +14.3%, avg unit volume $1.38M, +16% YoY; now sees 7-9 new restaurants in 2021, down from prior outlook for 10-15; anticipates system-wide unit growth of at least 8% next year O’Reilly Auto (ORLY) Q3 EPS $8.07 vs. est. $7.18; Q3 sales $3.48B vs. est. $3.3B; gross profit margin 52.3% vs. 52.4% y/y; raises year rev outlook to $12.9B-$13.2B from prior $12.3B-$12.6B (est. $12.73B) Sleep Number (SNBR) 3Q EPS $2.22 vs est. $1.44 on revs $640Mm vs est. $587.1Mm; sees FY EPS $7.25 vs est. $7.15; Spirit Airlines (SAVE) Q3 adj EPS ($0.69) was a narrower loss than est. ($1.02) on in-line revs $922.6M; load factor 77.6%, capacity +3.5% vs 3Q19; is slowing the pace to push back to full fleet utilization, expects to produce 53B-55B available seat miles in 2022 VICI Properties (VICI) 3Q adj FFO/shr $0.45 on revs $375.7Mm; guides FY adj FFO/shr $1.7901.80 vs est. $1.84 Wyndham Hotels (WH) 3Q EPS $1.09 vs est. $0.91 on net revs $463Mm vs est. $463Mm; guides FY RevPAR growth about 43%, sees fee-related and other revs $1.21-1.23B; guides FY adj EPS $2.93-3.03 vs est. $2.69 Yum China (YUMC) Q3 adj EPS $0.22 vs. est. $0.31; Q3 revs $2.55B vs. est. $2.51B; qtrly total system sales increased 1% year over year, with increases of 1% at both KFC and Pizza Hut, excluding f/x; increasing gross new stores target to over 1,700 in 2021; expect that covid-19, especially the delta variant outbreaks, will continue to affect consumer behavior and impact our same-store sales recovery. Solo Brands, Inc. (DTC) prices 12.9M share IPO at $17.00 per share Scientific Games Corp (SGMS) announces sale of lottery business to Brookfield business partners for $6.05 billion; deal consisting of $5.825 bln in cash & an earn-out of up to $225 mln based on achievement of certain ebitda targets in 2022 & 2023 Energy, Industrials & Materials Allison Transmission (ALSN) 3Q EPS $0.89 vs est. $0.90 on revs $567Mm vs est. $584Mm; guides FY sales $2.325-2.4B vs est. $2.36B Flowserve Corp. (FLS) 3Q adj EPS $0.29 vs est. $0.40 on revs $866.1Mm vs est. $899Mm; guides FY revs down 2-4% vs est. -2.3%, sees FY EPS $1.45-1.65 (was $1.40-1.45) vs est. $1.58, sees CAPEX $70-80Mm vs prior $65Mm Kraton (KRA) Q3 adj EPS $0.98 vs. est. $0.79; Q3 revs $526.9M vs. est. $459.1M; Polymer segment operating income of $43.8 million, compared to an operating loss of $5.1 million YoY; Chemical segment operating income of $35.7M, compared to an operating loss of $401.7M YoY Sunnova Energy (NOVA) Q3 EPS ($0.25) vs est. ($0.13) on revenue $68.9M vs est. $67.4M; reaffirmed FY21 view for adj EBITDA $80M-$85M, customer additions 55k-58k; set FY22 guidance for adj EBITDA $117M-$137M, customer additions 83k-87k Tronox Holdings (TROX) Q3 adj EPS $0.72 vs. est. $0.64; Q3 revs rose 29% to $870M vs. est. $905.3M United Rentals (URI) 3Q adj EPS $6.58 vs est. $6.80 on revs $2.6B vs est. $2.58B; guides FY revs $9.6-9.75B vs est. $9.6B, sees FY adj EBITDA $4.325-4.4B vs est. 4.3B Financials Aflac (AFL) Q3 adj EPS $1.53 vs. est. $1.32; Q3 revs $5.2B vs. est. $5.34B; in yen terms, Aflac Japan’s net premium income was ¥323.1 bln for quarter, or 4.0% lower than a year ago AvalonBay (AVB) Q3 core FFO $2.06 vs est. 1.97, EPS $0.56 vs est. $0.77, same-store sales +1.2%; sees Q4 core FFO $2.19-$2.29 vs est. $2.11, raised FY core FFO view to $8.18-$8.28 from $7.92-$8.12 CyrusOne Inc. (CONE) 3Q adj FFO/shr $1.02 vs est. $0.99 on revs $304.1Mm vs est. $290.4Mm; guides FY revs $1.18-1.2B vs est. $1.17B Invitation Homes (INVH) Q3 core FFO 38c/shr vs est. 36c, EPS 12c vs est. 10c, revenue $510M vs est. $497.8M; same-store NOI +11.9% YoY on same-store revs +7.9%; raised FY21 core EPS view to $1.49 at midpoint from $1.44, adj FFO ro $1.28 at midpoint from $1.24 Lending Club (LC) Q3 EPS $0.26 vs est. $0.03 on revenue $246.2M vs est. $221.2M; sees Q4 revs $240M-$250M vs est. $235.7M, loan originations $2.8-$3B; raised FY view for revenue to $796M-$806M from $750M-$780M Raymond James (RJF) Q4 EPS $2.06 vs. est. $1.71; Q4 revs $2.7B vs. est. $2.54B; quarter-end records for client assets under administration of $1.18 trillion, financial assets under management of $191.9B, and net loans at Raymond James Bank of $25B The SEC asked at least one asset manager not to proceed with plans for a leveraged bitcoin exchange-traded fund, according to a person familiar with the matter. The SEC indicated it wants to limit new bitcoin-related products to those that provide unleveraged exposure to bitcoin futures contracts, such as the ProShares Bitcoin Strategy exchange-traded fund, which was launched last week, the person said. https://on.wsj.com/3GvG2qg Healthcare Align Technology (ALGN) 3Q adj EPS $2.87 vs est. $2.60 on revs $1.02B vs est. $978Mm; guides FY revs $3.9-3.95B vs est. $3.94B; says clinical study validates benefits of the Itero Element 5D imaging system Alnylam (ALNY) reports positive topline 18-month results from Helios-a phase 3 study of Vutrisiran in patients with HATTR amyloidosis with polyneuropathy BioMarin (BMRN) Q3 GAAP EPS loss (-$0.20) vs. est. loss (-$0.25); Q3 revs $408.7M vs. est. $435.32M; Lower Kuvan product revenues primarily due to generic competition due to the loss of exclusivity in the U.S.; Lower Aldurazyme product revenues due to timing of product fulfillment to Genzyme Edwards LifeSciences (EW) Q3 EPS $0.54 vs. est. $0.53; Q3 revs $1.3B vs. est. $1.32B; sees FY21 adjusted EPS at high end of $2.07-$2.27 (est. $2.26) and reaffirms FY21 revenue view $5.2B-$5.4B (est. $5.32B); TAVR sales grew 15%; underlying 14%; U.S. TAVR sales grew 12%; OUS approximately 20% Encompass Health (EHC) Q3 adj EPS $1.03 vs. est. $1.06; Q3 revs $1.28B vs. est. $1.31B; cuts FY21 adj EPS view to $4.23-$4.38 from $4.32-$4.47 and lowers FY21 revenue view to $5.08B-$5.13B from $5.1B-$5.25B (est. $5.18B) Molina Healthcare (MOH) Q3 adj EPS $2.83 vs. est. $2.79; Q3 revs $7.04B vs. est. $6.79B; backs FY21 EPS view of no less than $13.25 vs. est. $13.38 and backs FY21 revenue view of no less than $27.5B vs. est. $26.97B; consolidated MCR for Q3 was 88.9%, compared to 85.9% in the third quarter of 2020 Teladoc (TDOC) Q3 EPS loss (-$0.53) vs. est. loss (-$0.65); Q3 revs $521.66M vs. est. $516.6M; Q3 visits topped 3.9M, 37% higher than Q3 2020; sees Q4 EPS loss (73c)-(53c) vs. est. loss (69c); sees Q4 revs $536M-$546M vs. est. $539.74M; sees Q4 total visits 3.9M-4.1M

69 Replies 12 👍 11 🔥

profile
@Pyrognosis #droscrew
recently

$DVA building inside day,maybe

146 Replies 11 👍 15 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Wednesday, August 4, 2021 Futures Up/Down % Last Dow -25.00 0.07% 34,973 S&P 500 -1.25 0.04% 4,413 Nasdaq 11.50 0.08% 15,058 U.S. S&P futures are flat heading into the trading day, looking to build on record highs from Tuesday as positive earnings boost U.S and European stocks while worries over China’s gaming and technology crackdown ease, helping lift those markets. Risk sentiment improves across Asia as Chinese and Hong Kong stocks push higher on tech recovery and solid Caixin PMI data. In Asian markets, The Nikkei Index fell -57 points to 27,854, the Shanghai Index rose 29 points to 3,477 and the Hang Seng Index jumped 231 points to settle at 26,426. In Europe, the German DAX is climbing around 125 points to 15,680, while the FTSE 100 is up 0.4% to 7,135. Chinese Jul Caixin Services PMI beat: 54.9 vs 50.6 consensus. Some also see the spread of the Covid-19 delta variant as delaying rather than stopping the economic recovery. The New York Times reported overnight that the FDA plans to give full approval to Pfizer (PFE) and BioNTech (BNTX) coronavirus vaccine by the start of the next month. Earnings season has been strong with about 87% of S&P 500 companies reporting earnings and revenue beats, according to FactSet. Just under 70% of the S&P 500 now has reported earnings. The S&P 500 closed at record highs with gains in Apple and healthcare stocks, as concerns over a surge in the Delta variant of the coronavirus was put to the back-burner, overshadowed by continued upbeat corporate earnings. Ten of the 11 S&P indexes traded higher, with energy stocks rebounding after getting hit by a dip in oil prices. Market Closing Prices Yesterday The S&P 500 Index gained 35.99 points, or 0.82%, to 4,423.15 The Dow Jones Industrial Average rose 278.24 points, or 0.80%, to 35,116.40 The Nasdaq Composite climbed 80.23 points, or 0.55%, to 14,761.29 The Russell 2000 Index advanced 8.09 points, or 0.36% to 2,223.58 Events Calendar for Today 7:00 AM ET MBA Mortgage Applications Data 8:15 AM ET ADP Employment Change for July…est. 695K 9:45 AM ET Markit Composite PMI, July-F 9:45 AM ET Markit Services PMI, July-F 10:00 AM ET ISM Non-Manufacturing Services PMI for July…est. 60.5 10:30 AM ET Weekly DOE Inventory Data Earnings Calendar: Earnings Before the Open: ABC, AEIS, ALE, APO, ASTE, BCOR, BDC, BGCP, BWA, CDW, CLVS, CLH, CLW, CMLS, CRL, CSII, DNOW, DOC, EDIT, EMR, ETR, EXC, FLOW, FUN, GEL, GM, HDSN, HFC, HZNP, IONS, JLL, KHC, LL, MAC, MKL, MPC, MPLX, MTOR, NI, NYT, ODP, RCL, SBGI, SGRY, SITE, SMG, SPR, SUP, TGI, TUP, TXMD, UTHR, VCEL, VMC, WLL Earnings After the Close: ACAD, ACLS, ADPT, ADTN, AGL, ALB, ALL, AMED, ANGI, ANSS, APA, ATO, AXGN, BBSI, BE, BFAM, BKNG, BOOT, CCMP, CDAY, CENX, CHNG, CMP, CPS, DGII, DOX, DVAX, DXC, EA, EGHT, ELF, EMKR, EOG, ETSY, EVH, FLT, FOXA, FSLY, FTDR, GDDY, GNK, HI, HUBS, IAC, INGN, IVR, JACK, LESL, LNC, LPI, LUMN, MAXR, MBI, MCK, MED, MET, MGM, MOD, MRO, MTG, NUS,NVRO, ONEM, PARR, PDCE, $PING, PLYA, QRVO, QTWO, RCII, REGI, RGR, RMAX, RNWK, EOKU, RPD, $RVLV, RYN, SBRA, SMSI, SUM, T$NDM, TPC, TTGT, TVTY, TWNK, TWO, TXG, $UBER, UHAL, VVV, VZIO, WDC, WU, YELL Other Key Events: Jefferies Industrials Conference (virtual), 8/3-8/4 Piper Wealth Management Forum (virtual), 8/3-8/6 Macro Up/Down Last Nymex -0.34 70.22 Brent -0.18 72.23 Gold 3.30 1,813.75 EUR/USD -0.0008 1.1856 JPY/USD 0.13 109.17 10-Year Note +0.008 1.182% Sector News Breakdown Consumer Caesar’s Entertainment ($CZR) Q2 EPS $0.34 vs. est. loss (-$0.26); Q2 revs $2.5B vs. est. $2.27B; Q2 same-store Adjusted EBITDA was $1B versus (-$131M) for the comparable prior-year period; Company posted all-time records in quarterly Adjusted EBITDA and Adjusted EBITDA margin. Denny’s ($DENN) Q2 adj EPS $0.18 vs. est. $0.11; Q2 revs $106.2M vs. est. $98.1M; Q2 domestic system-wide same-store sales decreased 1.2% compared to the equivalent fiscal period in 2019, including a 1.5% decrease at domestic franchised restaurants and a 1.9% increase at company restaurants. Herbalife ($HLF) Q2 adj EPS $1.52 vs. est. $1.29; Q2 revs $1.55B vs. est. $1.57B; Q2 adjusted EBITDA of $262.1M; raises FY21 EPS view to $4.70-$5.10 from $4.65-$5.05 (est. $4.93); sees FY net sales growth to be in a range of 8.5% to 12.5%, lowering the midpoint by 150 basis points compared to prior full year 2021 guidance. Host Hotels ($HST) Q2 adj FFO $0.12 vs. est. $0.04; Q2 revs $649M vs. est. $606.58M; said RevPAR reached nearly $100 for the quarter, which dramatically outperformed consensus RevPAR, with average room rates only 8.4% below our 2019 second quarter rates; not providing year guidance Hyatt ($H) 2Q adj EPS ($1.15) vs est. ($0.85) on comparable system-wide REVPAR $72.47, qtrly total revs $663Mm vs est. $686.9Mm; guides FY net rooms growth more than +6%, sees FY adj SG&A about $240Mm, sees FY CAPEX about $110Mm Energy Devon Energy ($DVN) Q2 adj EPS $0.60 vs est. $0.52 on revs $2.42B vs est. $2.35B, operating cash flow $1.1B, production for the quarter averaged 291k barrels/day; will pay total dividend of 49c/shr (11c fixed + 38c variable), a 44% increase from Q1; sees 3q production 566-594 mboe/d vs est. 564.80 mboe/d Occidental Petroleum ($OXY) Q2 adj EPS 32c vs est. 1c on revs $5.96B vs est. $5.92B, FCF $2B, cash flow from continuing operations $3.3B; said oil and gas results improved from Q1 due to higher commodity prices and sales volumes; executed debt tender offer and repaid over $3B of long-term debt in July ONEOK ($OKE) Q2 EPS $0.77 vs. est. $0.75; Q2 revs $3.39B vs. est. $3.03B; sees 2021 net income, adj earnings before interest, taxes, depreciation, amortization to be above midpoints of ranges provided on April 27, 2021 SunPower ($SPWR) Q2 adj EPS $0.06 vs. est. $0.04; Q2 revs $308.9M vs. est. $327.31M; guides Q3 revs $325M-$375M vs. est. $400.83M; sees Q3 GAAP net loss of $10 to $0 million and MW recognized of 125 MW to 150 MW; Q2 added 13,000 residential customers – residential bookings up 16 percent sequentially, 67 percent year-over-year (YoY) The American Petroleum Institute ($API) showed a draw of 879K barrels of oil for the latest week; gasoline inventories show a draw of 5.75M barrels, distillate inventories show a draw of 717K barrels and Cushing inventories show a build of 659K barrels W&T Offshore ($WTI) Q2 EPS $0.02 vs. est. $0.07; Q2 revs $132.8M vs. est. $122.38M; Q2 Production was 40,888 Boe/d or 3.7 MMBoe, an increase of 3% compared to 39,657 Boe/d in Q1 and down 3% versus 42,037 Boe/d in Q2 of 2020 Financials Assurant Inc. ($AIZ) Q2 operating EPS $2.99 vs. est. $2.45; Q2 revs $2.54B vs. est. $2.39B; continue to expect to grow eps, ex. catastrophes, by 10 to 14 percent for 2021 Fair Isaac ($FICO) Q3 non-GAAP EPS $3.38 vs. est. $2.76; Q3 revs $338M vs. est. $328.3M; Applications revenues, which include the company’s decision management applications and associated professional services, were $133.2 million in the third quarter, compared to $141.5 million in the prior year period, a decrease of 6% Genworth Financial ($GNW) Q2 adj EPS $0.38 vs. est. $0.22; Q2 revs $2.04B vs. est. $1.9B; planned IPO of Enact remains a key strategic objective for Genworth and is subject to market and other conditions, however because the company is in registration and subject to applicable publicity restrictions, is unable to comment further or provide any additional detail at this time. Green Dot ($GDOT) Q2 adj EPS $0.68 vs est. $0.43 on revs $369.4M vs est. $313.2M; sees FY21 adj EPS $2.13-$2.27 vs prev. $2.06-$2.15, revs $1.33B-$1.35B vs est. $1.28B Prudential ($PRU) Q2 adj EPS $3.79 vs. est. $3.02; qtrly book value per common share of $160.31 versus $165.53 per share for year-ago; qtrly adjusted book value per common share of $104.39 versus $92.07 per share for year-ago; qtr end assets under management of $1.730 trillion versus $1.605 trillion for year-ago; now expect to return a total of $11.0B to holders from $10.5B prior Tanger Outlets ($SKT) 2Q core FFO/shr $0.43 vs est. $0.28, portfolio occupancy was 93% on June 30 vs 91.7% on March 31, avg tenant sales productivity was $424/sq ft for 12 months ended June 30 +7.3% yr/yr; guides FY FFO/shr $1.52-1.59 vs est. $1.46 Unum Group (UNM) Q2 adj EPS $1.39 vs. est. $1.11; Q2 revs $2.99B vs. est. $2.96B; Full-year 2021 outlook increased; after-tax adjusted operating income per share now expected to decline 1%-3% relative to full-year 2020, compared to an expected decline of 5%-6% prior Verisk Analytics ($VRSK) Q2 adj EPS $1.17 vs. est. $1.33; Q2 revs $747.5M vs. est. $737.3M; Net cash provided by operating activities was $233.2 million, down 6.5% for the second quarter of 2021. Free cash flow, a non-GAAP measure, was $170.7 million, down 11.5% Healthcare Change Healthcare ($CHNG) shares fell over 7% on a report that the U.S. Dept. of Justice is considering a lawsuit to block the company’s $8B sale to UnitedHealth ($UNH) https://bit.ly/3yA4Etu Option Care Health ($OPCH) 18M share Spot Secondary priced at $20.25 Amgen Inc. ($AMGN) Q2 adj EPS $4.38 vs. est. $4.06; Q2 revs $6.5B vs. est. $6.43B; backs FY21 adj EPS view $16.00-$17.00 vs. est. $16.34; backs FY21 revenue view $25.8B-$26.6B vs. est. $26.04B Amid surge in new COVID-19 infections across U.S., the FDA plans to give full approval to Pfizer (PFE) – BioNTech (BNTX) coronavirus vaccine by the start of the next month, The New York Times reports The FDA classified the recent recall of some of Philips’ (PHG) ventilators as Class 1, or the most serious type of recall, saying the use of these devices may cause serious injuries or death – Reuters CVS Health ($CVS) Q2 adj EPS $2.42 vs. est. $2.06; Q2 revs $72.62B vs. est. $70.11B; raises FY21 adjusted EPS view to $7.70-$7.80 from $7.56-$7.68 (est. $7.66); sees FY21 cash flow from operations $12.5B-$13B DaVita Inc. (DVA) 2Q EPS $2.64 vs est. $2.17; says total US dialysis treatments for 2Q were 7,413497 (avg 95,045/day); guides FY adj EPS $8.80-9.40 vs est. $8.63, sees FY adj op income $1.8-1.875B vs est. $1.816B Inspire Medical ($INSP) 2Q EPS ($0.48) vs est. ($0.64) on revs $53Mm vs est. $43.9Mm; guides FY revs $210-213Mm vs est. $195.9Mm, sees FY gr mgn 85-86%, sees opening 48-52 new US medical centers per qtr for 2H Jazz Pharma ($JAZZ) Q2 adj EPS $3.90 vs. est. $3.42; Q2 revs $751.8M vs. est. $735.62M; reaffirms FY21 non-GAAP EPS view $13.40-$14.70 (est. $14.45) and also back FY21 revenue view $3.020B-$3.180B vs. est. $3.11B; as of June 30, cash, cash equivalents were $891.4 mln, and outstanding principal balance of co’s long-term debt was $7.1 bln

56 Replies 8 👍 13 🔥

profile
@dros #droscrew
recently

RECAP 7/15 Chatter: $AMKR + MBK Partners $GPX + Learning Technologies, $20.85 $EVGO + $GM Prefered Provider $DKNG + LA Daily Fantasy license $CCL $RCL $NCLH + Canada allow November $CCL + 2022 better than 2019, CEO $SPB + Hardware & Home Unit sale $DVA - DOJ

62 Replies 13 👍 8 🔥

profile
@Snowcow #droscrew
recently

I like that $DVA also

88 Replies 12 👍 7 🔥

profile
@RedSunCap #droscrew
recently

DVA always been good to me

88 Replies 11 👍 13 🔥

profile
@RedSunCap #droscrew
recently

937 $DVA April21 115 calls trade 7.00 // 1000 vs 4

44 Replies 10 👍 14 🔥

profile
@RedSunCap #droscrew
recently

937 $DVA April21 115 calls trade 7.00 // 1000 vs 4

137 Replies 12 👍 10 🔥

profile
@CarlosH-carvan #ivtrades
recently

3,000 $DVA 100 15 JAN 21 97.5 CALL @2.10 LMT

127 Replies 9 👍 10 🔥

profile
@dros #droscrew
recently

6200 of the puts on the dva too

41 Replies 8 👍 13 🔥

profile
@dros #droscrew
recently

6200 $DVA 25SEP20 $100 Cs bought 0.90

67 Replies 10 👍 8 🔥

TI
@Titus #StockTraders.NET
recently

selling DVA for + 2

105 Replies 10 👍 6 🔥

TI
@Titus #StockTraders.NET
recently

long DVA 87

68 Replies 9 👍 14 🔥

profile
@dros #droscrew
recently

BANK OF AMERICA: Q2 EPS 37C VS 74C (YOY) Q2 TRADING REV EX DVA 4.41B; EST. 3.83B Q2 FICC TRADING REV EX-DVA 3.19B, EST. 2.57B Q2 EPS 37C, EST. 25C

43 Replies 14 👍 11 🔥

CO
@CocoMayen #Zona Trading
recently

$DVA increible como repitió lo de hace unos meses

131 Replies 8 👍 13 🔥

CO
@CocoMayen #Zona Trading
recently

caso interesante DVA, esta repitiendo lo que hizo el 11 y 12 de febrero, una resistencia significativa casi en $90

84 Replies 9 👍 15 🔥

profile
@zonatrading #Zona Trading
recently

$DVA por dios como no entre ajajja

102 Replies 10 👍 13 🔥

profile
@haleksander #Zona Trading
recently

con mi alarma de $DVA me paso como con mi alarma para levantarme, no la oí jajaja

146 Replies 14 👍 10 🔥

CO
@CocoMayen #Zona Trading
recently

$DVA esta increíble el break out

62 Replies 6 👍 15 🔥

profile
@zonatrading #Zona Trading
recently

$DVA impresionante

98 Replies 10 👍 8 🔥

CO
@CocoMayen #Zona Trading
recently

$DVA rompiendo magnificamente 💓

102 Replies 11 👍 6 🔥

CO
@CocoMayen #Zona Trading
recently

$DVA la esta haciendo... $CNC no

146 Replies 14 👍 6 🔥

profile
@zonatrading #Zona Trading
recently

DVA Y CNC cotizan en el mismo sector

81 Replies 7 👍 7 🔥

CO
@CocoMayen #Zona Trading
recently

$DVA es otra que me tiene picado... ya va

65 Replies 8 👍 15 🔥

Key Metrics

Market Cap

9.22 B

Beta

0.68

Avg. Volume

765.35 K

Shares Outstanding

94.60 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-04

Next Dividend Date

Company Information

DaVita Inc. is a health care provider focused on transforming care delivery to improve quality of life for patients globally. The company is one of the largest providers of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years. Through DaVita Kidney Care, the company treats patients with chronic kidney failure and end stage kidney disease. DaVita is committed to bold, patient-centric care models, implementing the latest technologies and moving toward integrated care offerings for all. Through these efforts, DaVita has also become the largest provider of home dialysis in the country. As of December 31, 2020, DaVita served 204,200 patients at 2,816 outpatient dialysis centers in the United States. The company also operated 321 outpatient dialysis centers in ten countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere.

CEO: Javier Rodriguez

Website:

HQ: 2000 16th St Denver, 80202-5117 Colorado

Related News